Tamara Minko
Tamara Minko is a distinguished pharmacologist and professor known for her significant contributions to the field of pharmacology. She is currently serving as a professor at the Rutgers University, where she has been a faculty member since 1998.
Early Life and Education[edit | edit source]
Tamara Minko was born and raised in Ukraine. She completed her undergraduate studies in Chemistry at the National University of Kyiv, where she developed a keen interest in the field of pharmacology. She then pursued her Ph.D. in Pharmaceutical Chemistry from the same university.
Career[edit | edit source]
After completing her Ph.D., Minko moved to the United States and joined Rutgers University as a faculty member in the Department of Pharmaceutics. Her research primarily focuses on the development of novel drug delivery systems and nanotechnology-based therapeutics for the treatment of cancer and inflammatory diseases.
Minko has published numerous research articles in reputed scientific journals and has been awarded several patents for her innovative work in drug delivery systems. She is also a member of various professional organizations, including the American Association of Pharmaceutical Scientists and the American Chemical Society.
Contributions to Pharmacology[edit | edit source]
Minko's research has significantly advanced the field of pharmacology, particularly in the area of drug delivery systems. Her work has led to the development of innovative therapeutic strategies for the treatment of various diseases, including cancer and inflammatory diseases. Her research has also contributed to the understanding of the mechanisms of drug action and resistance.
Awards and Recognition[edit | edit source]
Minko's contributions to the field of pharmacology have been recognized with several awards and honors. She was awarded the Rutgers University Board of Trustees Research Fellowship for Scholarly Excellence in 2004, and the American Association of Pharmaceutical Scientists Research Achievement Award in Drug Delivery in 2015.
See Also[edit | edit source]
References[edit | edit source]
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
